Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

P eople with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart ...

and glucagon suppression are physiological manifestations of the incretin effect. Glucose tolerance and obesity impair the incretin effect independently of one another.

The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study,” published in ...

People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart ...

Incretins are intestinal hormones secreted in response to nutrient entry into the gut, inducing insulin secretion and inhibiting glucagon release. While this response is diminished in individuals with ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...

People with hidden pockets of fat in their muscles – similar to so-called marbling in beef – are at a higher risk of dying ...